PPA says the Pharmacy Guild is making “increasingly desperate attacks” on the King Review
Professional Pharmacists Australia says it is concerned about the potential impact on the sector of what it calls “increasingly desperate” attacks by the Pharmacy Guild on the Federal Government’s independent Review of Remuneration and Regulation.
“The Pharmacy Guild’s extraordinary claims of a conflict of interest compromising the independence of the Pharmacy Remuneration and Regulation Review appear to be completely over baked,” says PPA National Campaign Director, Matt Harris.
“These tactics are nothing new, nor are they particularly creative. The Guild can’t control the review, so instead of engaging constructively, they go on to suggest that there are integrity issues with the Review Chair and the international consultancy firm, Deloitte.
“The Guild have presented no hard evidence of a conflict of interest, but have sought to go public nonetheless. Are they really suggesting that Deloitte and the Review Panel are acting improperly?
“It smacks of desperation,” says Harris.
“Pharmacy owners and employees should be concerned about the Guild’s preparedness to paint itself into a corner. In all professions, change occurs, and it involves transition.
“We all have a choice to participate in that change, or throw rocks from the sidelines. Surely, it’s better for patients that pharmacists engage constructively in this process?
“We know that community pharmacy faces significant challenges, and we need to face up to this reality. PPA has always supported this review as an opportunity for pharmacists to be involved in building stronger foundations for the future.
“We won’t be changing this approach based on the Guild’s unsubstantiated claims,” Harris says.
Harris also took aim at the Guild this morning over the TGA’s decision to upschedule codeine-containing products from 1 February 2018.
Surely the Pharmacy Guild can't be that surprised at the govt's decision to upschedule codeine?
— Matt Harris (@Matt_at_PPA) December 19, 2016
When will the Pharmacy Guild suggest that KPMG has a conflict of interest in providing modelling for the decision to up-schedule codeine. pic.twitter.com/SGjc7kGrG5
— Matt Harris (@Matt_at_PPA) December 20, 2016